Conditions: Prostatic Neoplasms; Prostatic Diseases; Prostate Cancer; Prostate Cancer Metastatic; Prostate Cancer Recurrent
Intervention: Drug: 68GA PSMA-HBED-CC
Sponsors: Jeanne Link; OHSU Center of Radiochemistry Research; Oregon Health and Science University; OHSU Knight Cancer Institute
Available
Intervention: Drug: 68GA PSMA-HBED-CC
Sponsors: Jeanne Link; OHSU Center of Radiochemistry Research; Oregon Health and Science University; OHSU Knight Cancer Institute
Available
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
